Modulation of signal transduction by tea catechins and related phytochemicals

被引:107
作者
Shimizu, M
Weinstein, IB
机构
[1] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[2] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA
关键词
phytochemicals; EGCG; cell signaling pathway; RTK;
D O I
10.1016/j.mrfmmm.2005.04.010
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Epidemiologic studies in human populations and experimental studies in rodents provide evidence that green tea and its constituents can inhibit both the development and growth of tumors at a variety of tissue sites. In addition, EGCG, a major biologically active component of green tea, inhibits growth and induces apoptosis in a variety of cancer cell lines. The purpose of this paper is to review evidence that these effects are mediated, at least in part, through inhibition of the activity of specific receptor tyrosine kinases (RTKs) and related downstream pathways of signal transduction. We also review evidence indicating that the antitumor effects of the related polyphenolic phytochemicals resveratrol, genistein, curcumin, and capsaicin are exerted via similar mechanisms. Some of these agents (EGCG, genistein, and curcumin) appear to directly target specific RTKs, and all of these compounds cause inhibition of the activity of the transcription factors AP-1 and NF-kappa B, thus inhibiting cell proliferation and enhancing apoptosis. Critical areas of future investigation include: (1) identification of the direct molecular target(s) of EGCG and related polyphenolic compounds in cells; (2) the in vivo metabolism and bioavailability of these compounds; (3) the ancillary effects of these compounds on tumor-stromal interactions; (4) the development of synergistic combinations with other antitumor agents to enhance efficacy in cancer prevention and therapy, and also minimize potential toxicities. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 160
页数:14
相关论文
共 121 条
[91]   Development of anticancer drugs targeting the MAP kinase pathway [J].
Sebolt-Leopold, JS .
ONCOGENE, 2000, 19 (56) :6594-6599
[92]   Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involved [J].
She, QB ;
Ma, WY ;
Wang, MF ;
Kaji, A ;
Ho, CT ;
Dong, ZG .
ONCOGENE, 2003, 22 (14) :2143-2150
[93]   (-)-epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells [J].
Shimizu, M ;
Deguchi, A ;
Lim, JTE ;
Moriwaki, H ;
Kopelovich, L ;
Weinstein, IB .
CLINICAL CANCER RESEARCH, 2005, 11 (07) :2735-2746
[94]   Nuclear factor-KB: a friend or a foe in cancer? [J].
Shishodia, S ;
Aggarwal, BB .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) :1071-1080
[95]   ACTIVATION OF TRANSCRIPTION FACTOR NF-KAPPA-B IS SUPPRESSED BY CURCUMIN (DIFERULOLYLMETHANE) [J].
SINGH, S ;
AGGARWAL, BB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :24995-25000
[96]  
Soh JW, 1999, MOL CELL BIOL, V19, P1313
[97]   Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells [J].
Squires, MS ;
Hudson, EA ;
Howells, L ;
Sale, S ;
Houghton, CE ;
Jones, JL ;
Fox, LH ;
Dickens, M ;
Prigent, SA ;
Manson, MM .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (03) :361-376
[98]   Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKCα inhibition [J].
Stewart, JR ;
O'Brian, CA .
INVESTIGATIONAL NEW DRUGS, 2004, 22 (02) :107-117
[99]   RETRACTED: Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway (Retracted Article. See vol 24, pg 1964, 2005) [J].
Stoica, GE ;
Franke, TF ;
Wellstein, A ;
Morgan, E ;
Czubayko, F ;
List, HJ ;
Reiter, R ;
Martin, MB ;
Stoica, A .
ONCOGENE, 2003, 22 (14) :2073-2087
[100]   Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B [J].
Stokoe, D ;
Stephens, LR ;
Copeland, T ;
Gaffney, PRJ ;
Reese, CB ;
Painter, GF ;
Holmes, AB ;
McCormick, F ;
Hawkins, PT .
SCIENCE, 1997, 277 (5325) :567-570